Concepedia

Mark Lindrud

ML

Statistics

Publications

8

Citations

263

H-Index

8

Active since

2002

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Mark Lindrud is an author at Bristol-Myers Squibb (United States) specializing in pharmacy, pharmaceutical formulation, and drug discovery.

Publications per year

2002–2019

8

Publications

8

Control of the Particle Properties of a Drug Substance by Crystallization Engineering and the Effect on Drug Product Formulation

Soojin Kim, Bruce Lotz, Mark Lindrud et al. · Organic Process Research & Development · 2005 · 67 citations

, , +17

Process Research and Development for an Efficient Synthesis of the HIV Protease Inhibitor BMS-232632

Zhongmin Xu, Janak Singh, Mark D. Schwinden et al. · Organic Process Research & Development · 2002 · 63 citations

, , +16

A Practical Stereoselective Synthesis and Novel Cocrystallizations of an Amphiphatic SGLT-2 Inhibitor

Prashant P. Deshpande, Janak Singh, Annie Pullockaran et al. · Organic Process Research & Development · 2012 · 38 citations

, , +8

Development and Demonstration of a Safer Protocol for the Synthesis of 5-Aryltetrazoles from Aryl Nitriles

Daniel S. Treitler, Simon Leung, Mark Lindrud · Organic Process Research & Development · 2017 · 24 citations

, , +12

A Process for Active Pharmaceutical Ingredient Recovery from Tablets Using Green Engineering Technology

Daniel S. Hsieh, Mark Lindrud, Xujin Lu et al. · Organic Process Research & Development · 2017 · 24 citations

, , +17

1–5 of 8